The "Cardiac Resynchronization Therapy (CRT) - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The cardiac resynchronization therapy ...

The U.S. cardiac resynchronization therapy market was valued at $965.6 million in 2019, and is projected to reach $983.3 million by 2027, registering a CAGR of 4.9% from 2020 to 2027. Surge in ...

In the CONDUCT-TAVI study, the use of a self-expanding valve was not associated with an increased risk of pacemaker.

Accelerating the heart rhythm may offer a new treatment option for patients with diastolic heart failure and atrial ...

The A-HIRATE Trial was a multicenter, prospective study assessing the incidence of atrial high rate episodes (AHRE) in pacemaker patients with and without previously diagnosed AT. The trial was ...

The report ‘Cardiac Rhythm Management Devices Market Share, Size, Trends & Industry Analysis By Product (Pacemakers, Cardiac Resynchronization Therapy (CRT), and Defibrillators), By Regions: Segment ...

A pacemaker may be useful for atrial fibrillation (AFib ... electrical impulses to the heart to encourage a regular heart rhythm. People who get pacemakers may also need to take blood-thinning ...

Abbott has launched a pacemaker in India for the treatment of patients with slow heart rhythms. Abbott has introduced AVEIR VR single-chamber ventricular leadless pacemaker which has been approved by ...